Skip to content
ClinCalc Pro
Menu
Alpha-adrenoceptor agonist (nasal decongestant)

Xylometazoline hydrochloride

Brand names: Otrivin, Sudafed Blocked Nose, Sinex

Xylometazoline is a topical imidazoline sympathomimetic decongestant applied intranasally to relieve nasal congestion in conditions such as the common cold, rhinitis and sinusitis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is an alpha-adrenoceptor agonist that constricts dilated nasal blood vessels, reducing mucosal swelling and oedema to improve airflow.

Prescribing in practice

  • Limit continuous use to a short course only, as prolonged use causes rebound congestion (rhinitis medicamentosa).
  • Avoid or use with caution in patients with cardiovascular disease, hypertension, hyperthyroidism, diabetes or those taking monoamine oxidase inhibitors.
  • Paediatric formulations of lower strength exist; check a children's formulary for age-appropriate use and avoid in very young children unless specifically indicated.

Monitoring

Routine laboratory monitoring is not required; review symptomatic response and discourage prolonged or excessive use.

Counselling the patient

  • Use for only a few days at a time to avoid worsening congestion when you stop.
  • Do not share the nasal device with others to prevent spreading infection.
  • Seek advice if symptoms persist or worsen.

Evidence & guidelines

Topical nasal decongestants are well established for short-term symptomatic relief of nasal congestion as reflected in the SPC and current prescribing references.

Reference: NICE CKS; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.